OSCR

Glial and Vascular Plasma Biomarkers Across the Alzheimer's Disease Continuum: An ADNI-Based Longitudinal Study.

Code ↔ Paper

17 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

14 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.

The 17 matches
  1. [1] § Materials and Methods › Biomarker Harmonization and Transformation ↔ 13_revision_diagnostics.R, lines 112 to 158 · score 0.83 · regression slope, natural log, raw multiplex, sVCAM, sICAM, pg · block oscr:b:QZRZYN6NJKP1D-J · Report a mismatch
  2. [2] § Materials and Methods › Study Design and Data Source ↔ 06_merge_selected_biomarkers.R, lines 146 to 185 · score 0.80 · intercellular adhesion molecule, vascular endothelial growth, vascular cell adhesion, Plasma, biomarker · block oscr:b:CY8PB329C7309-6 · Report a mismatch
  3. [3] § Materials and Methods › Sensitivity Analyses ↔ 15_sensitivity_analyses.R, lines 309 to 389 · score 0.77 · informative dropout, stable MCI, AD converters, baseline biomarker, split, predicted · block oscr:b:DVGT0MT7S89GS-9 · Report a mismatch
  4. [4] § Materials and Methods › Study Design and Data Source ↔ 13_revision_diagnostics.R, lines 160 to 246 · score 0.74 · vascular endothelial growth, vascular cell adhesion, intercellular adhesion, protein, Plasma · block oscr:b:186Y7PWFAAF28-K · Report a mismatch
  5. [5] § Results › Sensitivity Analyses ↔ 15_sensitivity_analyses.R, lines 309 to 389 · score 0.70 · conversion rates, MCI converted, stable MCI, AD converters, analytic, Sensitivity · block oscr:b:DVGT0MT7S89GS-9 · Report a mismatch
  6. [6] § Materials and Methods › Biomarker Harmonization and Transformation ↔ 15_sensitivity_analyses.R, lines 91 to 130 · score 0.69 · Myriad RBM, Biomarkers Consortium, sICAM, vascular · block oscr:b:68FBHR6T9CY7T-6 · Report a mismatch
  7. [7] § Materials and Methods › Biomarker Harmonization and Transformation ↔ 14_corrected_primary_analysis.R, lines 50 to 100 · score 0.67 · sVCAM, sTREM2, sICAM, pg, log10, coefficients · block oscr:b:CJ3692SXFHWH4-F · Report a mismatch
  8. [8] § Results › Baseline Glial‐Vascular Correlation Structure ↔ 07_baseline_and_longitudinal_analysis.R, lines 336 to 425 · score 0.66 · correlation heatmap, Baseline glial vascular, Spearman correlations, Tile, log, diagnostic · block oscr:b:70BCZ4TM8J10C-K · Report a mismatch
  9. [9] § Materials and Methods › Vascular Risk Factor Adjustment ↔ 18_risk_adjustment_repaired.R, lines 350 to 421 · score 0.63 · renal function, blood pressure, antidiabetic, antihypertensive, smoking, Risk · block oscr:b:5H470AX7TGD4R-Y · Report a mismatch
  10. [10] § Materials and Methods › Biomarker Harmonization and Transformation ↔ 05_biomarker_candidate_QA.R, lines 40 to 107 · score 0.63 · Biomarkers Consortium, Haass, Proteomics, WashU, sTREM2, Quanterix · block oscr:b:W3DEMYTPE23K9-4 · Report a mismatch
  11. [11] § Results › Baseline Biomarker Distributions ↔ 14_corrected_primary_analysis.R, lines 50 to 100 · score 0.63 · plasma GFAP, sVCAM, sTREM2, sICAM, ng, pg · block oscr:b:CJ3692SXFHWH4-F · Report a mismatch
  12. [12] § Materials and Methods › Baseline Analysis ↔ 14_corrected_primary_analysis.R, lines 355 to 406 · score 0.59 · overlap coefficient, Cohen, unadjusted, detectable, discriminative, power · block oscr:b:NMFZQN57XH6XZ-G · Report a mismatch
  13. [13] § Results › Sensitivity Analyses ↔ 17_fixes_and_risk_covariates (1).R, lines 514 to 593 · score 0.58 · Vascular risk, vascular models, unadjusted, antidiabetic, antihypertensive, smoking · block oscr:b:9MWZN28KYRR0N-O · Report a mismatch
  14. [14] § Materials and Methods › Data Extraction and Cohort Construction ↔ 15_sensitivity_analyses.R, lines 243 to 307 · score 0.58 · conversion status, varying diagnosis, sensitivity, date, RID, MCI · block oscr:b:RZNAGETTSSW25-0 · Report a mismatch
  15. [15] § Materials and Methods › Correlation Analysis ↔ 07_baseline_and_longitudinal_analysis.R, lines 336 to 425 · score 0.56 · Baseline glial vascular, Spearman correlations, log, biomarker · block oscr:b:70BCZ4TM8J10C-K · Report a mismatch
  16. [16] § Materials and Methods › Multiple‐Comparison Correction ↔ 13_revision_diagnostics.R, lines 501 to 555 · score 0.52 · reported baseline, definitions, families, coefficient, intercept, sensitivity · block oscr:b:9AFEMQVB2C9WW-E · Report a mismatch
  17. [17] § Materials and Methods › Longitudinal Analysis ↔ 14_corrected_primary_analysis.R, lines 230 to 290 · score 0.50 · random slope, random intercept, Residual, visits, vascular, model · block oscr:b:QNPDXQSMFMS85-F · Report a mismatch

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 389 lines · 17 KB · MIT · 4 matches

  1. # ==========================================================
  2. # 15_sensitivity_analyses.R
  3. #
  4. # Sensitivity analyses requested by Reviewer 2 (comments 2, 3),
  5. # plus a batch-effect investigation of the vascular longitudinal
  6. # finding that neither reviewer raised but that determines how
  7. # that finding should be framed.
  8. #
  9. # Sections
  10. # A. Vascular batch / assay-run investigation
  11. # B. Restriction to participants with 2+ measurements (R2-2)
  12. # C. Restriction to 2+ years of follow-up (R2-2)
  13. # D. MCI converters and time-varying diagnosis (R2-3)
  14. # E. Informative dropout probe
  15. #
  16. # Run 14_corrected_primary_analysis.R first; this script repeats
  17. # the corrected outcome construction so it can stand alone.
  18. # ==========================================================
  19. needed <- c("tidyverse", "janitor", "openxlsx", "lme4", "lmerTest",
  20. "broom", "broom.mixed")
  21. missing <- needed[!needed %in% rownames(installed.packages())]
  22. if (length(missing) > 0) install.packages(missing)
  23. library(tidyverse); library(janitor); library(openxlsx)
  24. library(lme4); library(lmerTest); library(broom); library(broom.mixed)
  25. project_dir <- "R:/ADNI_Project"
  26. bio_dir <- file.path(project_dir, "00_raw_data", "biomarkers_excel")
  27. clean_dir <- file.path(project_dir, "02_clean_data")
  28. results_dir <- file.path(project_dir, "04_results")
  29. out <- list()
  30. parse_num <- function(x) readr::parse_number(as.character(x))
  31. first_nonmissing <- function(x) { x <- x[!is.na(x) & x != ""]; if (!length(x)) NA else x[1] }
  32. marker_info <- tribble(
  33. ~marker, ~label, ~stored_scale,
  34. "gfap_quanterix", "Plasma GFAP", "raw",
  35. "strem2_msd_corrected", "Plasma sTREM2", "raw",
  36. "vegf_plasma_qc", "Plasma VEGF", "log10",
  37. "sicam1_plasma_qc", "Plasma sICAM-1", "log10",
  38. "svcam1_plasma_qc", "Plasma sVCAM-1", "log10"
  39. )
  40. primary_markers <- marker_info$marker
  41. vascular_markers <- c("vegf_plasma_qc", "sicam1_plasma_qc", "svcam1_plasma_qc")
  42. dat <- read_csv(file.path(clean_dir, "analysis_master_model_ready.csv"),
  43. show_col_types = FALSE, guess_max = 100000) %>%
  44. clean_names() %>%
  45. mutate(
  46. rid = as.character(rid), visit_key = as.character(visit_key),
  47. dx_label = factor(dx_label, levels = c("CN", "MCI", "AD")),
  48. baseline_dx = factor(baseline_dx, levels = c("CN", "MCI", "AD")),
  49. ptgender = factor(ptgender), age = parse_num(age),
  50. pteducat = parse_num(pteducat), apoe4 = parse_num(apoe4),
  51. years_from_baseline = parse_num(years_from_baseline)
  52. ) %>%
  53. mutate(baseline_age = age - years_from_baseline)
  54. for (i in seq_len(nrow(marker_info))) {
  55. m <- marker_info$marker[i]; v <- parse_num(dat[[m]])
  56. dat[[paste0("ln_", m)]] <- if (marker_info$stored_scale[i] == "log10")
  57. log(10) * v else ifelse(!is.na(v) & v > 0, log(v), NA_real_)
  58. }
  59. long_cc <- function(m, d = dat) {
  60. d %>% filter(!is.na(.data[[paste0("ln_", m)]]), !is.na(years_from_baseline),
  61. !is.na(baseline_dx), !is.na(baseline_age), !is.na(ptgender),
  62. !is.na(pteducat), !is.na(apoe4))
  63. }
  64. reported_long <- c("years_from_baseline", "baseline_dxMCI", "baseline_dxAD",
  65. "years_from_baseline:baseline_dxMCI", "years_from_baseline:baseline_dxAD")
  66. fit_long <- function(m, d) {
  67. lmer(as.formula(paste0("ln_", m,
  68. " ~ years_from_baseline * baseline_dx + baseline_age + ptgender + pteducat + apoe4 + (1 | rid)")),
  69. data = d, REML = FALSE)
  70. }
  71. extract_long <- function(fit, m, tag) {
  72. tidy(fit, effects = "fixed") %>%
  73. filter(term %in% reported_long) %>%
  74. mutate(marker = m, analysis = tag,
  75. percent_change = (exp(estimate) - 1) * 100,
  76. n_obs = nobs(fit), n_subj = ngrps(fit)[["rid"]])
  77. }
  78. # ==========================================================
  79. # A. VASCULAR BATCH / ASSAY-RUN INVESTIGATION
  80. #
  81. # The vascular panel has exactly two visits, bl and m12, assayed
  82. # by Myriad RBM as part of the Biomarkers Consortium project.
  83. # The published sICAM-1 CN slope corresponds to roughly a 24%
  84. # fall in concentration over 12 months, which is not a plausible
  85. # biological rate. Three checks distinguish biology from a
  86. # run-to-run shift.
  87. # ==========================================================
  88. cat("\n=== A. Vascular batch investigation ===\n")
  89. # A1. Paired within-person change from bl to m12, by diagnosis.
  90. # A uniform shift across all three groups points to a batch
  91. # effect; a shift confined to one group points to biology.
  92. paired_change <- map_dfr(vascular_markers, function(m) {
  93. ln <- paste0("ln_", m)
  94. dat %>%
  95. filter(visit_key %in% c("bl", "m12"), !is.na(.data[[ln]]), !is.na(baseline_dx)) %>%
  96. select(rid, baseline_dx, visit_key, value = all_of(ln)) %>%
  97. pivot_wider(names_from = visit_key, values_from = value) %>%
  98. filter(!is.na(bl), !is.na(m12)) %>%
  99. mutate(delta = m12 - bl) %>%
  100. group_by(baseline_dx) %>%
  101. summarise(
  102. n = n(),
  103. mean_delta_log = mean(delta),
  104. percent_change_12m = (exp(mean(delta)) - 1) * 100,
  105. sd_delta = sd(delta),
  106. t_p = t.test(delta)$p.value,
  107. pct_declining = round(100 * mean(delta < 0), 1),
  108. .groups = "drop"
  109. ) %>%
  110. mutate(marker = m)
  111. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  112. print(as.data.frame(paired_change))
  113. out$A1_paired_change <- paired_change
  114. # A2. Is the bl-to-m12 shift the same in every group?
  115. # If the group differences vanish, the shift is common to all
  116. # samples and behaves like a run effect.
  117. out$A2_shift_homogeneity <- map_dfr(vascular_markers, function(m) {
  118. ln <- paste0("ln_", m)
  119. d <- dat %>%
  120. filter(visit_key %in% c("bl", "m12"), !is.na(.data[[ln]]), !is.na(baseline_dx)) %>%
  121. select(rid, baseline_dx, visit_key, value = all_of(ln)) %>%
  122. pivot_wider(names_from = visit_key, values_from = value) %>%
  123. filter(!is.na(bl), !is.na(m12)) %>%
  124. mutate(delta = m12 - bl)
  125. a <- aov(delta ~ baseline_dx, data = d)
  126. tibble(marker = m,
  127. overall_mean_shift_pct = (exp(mean(d$delta)) - 1) * 100,
  128. anova_p_group_difference = summary(a)[[1]][["Pr(>F)"]][1],
  129. interpretation = if (summary(a)[[1]][["Pr(>F)"]][1] > 0.05)
  130. "shift is uniform across groups -> consistent with a run effect"
  131. else "shift differs by group -> not explained by a uniform run effect")
  132. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  133. # A3. Independent source check. ADMC_CLINICALVARIABLES is a separate
  134. # processing of the same three analytes. If the 12-month drop
  135. # appears there too it is in the samples, not the QC pipeline.
  136. admc_path <- file.path(bio_dir, "ADMC_CLINICALVARIABLES_16May2016.csv")
  137. if (file.exists(admc_path)) {
  138. admc <- read_csv(admc_path, show_col_types = FALSE, guess_max = 100000) %>% clean_names()
  139. key_visit <- intersect(c("viscode2", "viscode"), names(admc))[1]
  140. admc_long <- admc %>%
  141. transmute(rid = as.character(rid), visit_key = as.character(.data[[key_visit]]),
  142. vegf_plasma_qc = parse_num(vegf),
  143. sicam1_plasma_qc = parse_num(icam),
  144. svcam1_plasma_qc = parse_num(vcam)) %>%
  145. group_by(rid, visit_key) %>%
  146. summarise(across(everything(), first_nonmissing), .groups = "drop") %>%
  147. mutate(across(all_of(vascular_markers), as.numeric)) %>%
  148. pivot_longer(all_of(vascular_markers), names_to = "marker", values_to = "admc_value")
  149. out$A3_admc_check <- admc_long %>%
  150. filter(visit_key %in% c("bl", "m12"), !is.na(admc_value), admc_value > 0) %>%
  151. left_join(dat %>% distinct(rid, baseline_dx), by = "rid") %>%
  152. mutate(ln_admc = log(admc_value)) %>%
  153. select(rid, marker, visit_key, ln_admc, baseline_dx) %>%
  154. pivot_wider(names_from = visit_key, values_from = ln_admc) %>%
  155. filter(!is.na(bl), !is.na(m12)) %>%
  156. group_by(marker) %>%
  157. summarise(n = n(), mean_delta_log = mean(m12 - bl),
  158. percent_change_12m = (exp(mean(m12 - bl)) - 1) * 100,
  159. t_p = t.test(m12 - bl)$p.value, .groups = "drop") %>%
  160. mutate(note = "compare percent_change_12m with sheet A1; agreement means the shift is in the samples")
  161. print(as.data.frame(out$A3_admc_check))
  162. } else {
  163. cat("ADMC file not found, skipping the independent source check.\n")
  164. }
  165. # A4. Does the raw multiplex release carry plate / run / batch fields?
  166. raw_path <- file.path(bio_dir, "adni_plasma_raw_multiplex_11Nov2010.csv")
  167. if (file.exists(raw_path)) {
  168. raw_mx <- read_csv(raw_path, show_col_types = FALSE, guess_max = 100000) %>% clean_names()
  169. batch_cols <- grep("plate|batch|run|assay|date|lot|kit", names(raw_mx),
  170. value = TRUE, ignore.case = TRUE)
  171. out$A4_batch_fields <- tibble(
  172. candidate_batch_columns = if (length(batch_cols)) paste(batch_cols, collapse = ", ")
  173. else "none found",
  174. all_columns = paste(names(raw_mx), collapse = " | ")
  175. )
  176. cat("Candidate batch fields in raw multiplex file:",
  177. if (length(batch_cols)) paste(batch_cols, collapse = ", ") else "none", "\n")
  178. }
  179. # ==========================================================
  180. # B. RESTRICTION TO PARTICIPANTS WITH 2+ MEASUREMENTS
  181. #
  182. # Participants with a single observation contribute nothing to
  183. # within-person slope estimation but do pull the pooled time
  184. # coefficient toward a between-person contrast.
  185. # ==========================================================
  186. cat("\n=== B. Two-or-more measurements ===\n")
  187. sens_2plus <- map_dfr(primary_markers, function(m) {
  188. d <- long_cc(m) %>% group_by(rid) %>% filter(n() >= 2) %>% ungroup()
  189. if (n_distinct(d$rid) < 30 || n_distinct(d$baseline_dx) < 2) return(NULL)
  190. extract_long(fit_long(m, d), m, "restricted to 2+ measurements")
  191. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  192. out$B_two_or_more_visits <- sens_2plus
  193. # Within-between (Mundlak) decomposition, which uses the whole sample
  194. # but separates within-person change from between-person differences.
  195. mundlak <- map_dfr(primary_markers, function(m) {
  196. d <- long_cc(m) %>%
  197. group_by(rid) %>%
  198. mutate(time_mean = mean(years_from_baseline),
  199. time_within = years_from_baseline - time_mean) %>%
  200. ungroup()
  201. if (sd(d$time_within, na.rm = TRUE) == 0) return(NULL)
  202. fit <- lmer(as.formula(paste0("ln_", m,
  203. " ~ time_within * baseline_dx + time_mean + baseline_age + ptgender +",
  204. " pteducat + apoe4 + (1 | rid)")), data = d, REML = FALSE)
  205. tidy(fit, effects = "fixed") %>%
  206. filter(grepl("time_within|time_mean", term)) %>%
  207. mutate(marker = m, percent_change = (exp(estimate) - 1) * 100,
  208. reading = if_else(grepl("time_mean", term),
  209. "between-person component",
  210. "within-person component"))
  211. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  212. out$B_within_between <- mundlak
  213. # ==========================================================
  214. # C. RESTRICTION TO 2+ YEARS OF FOLLOW-UP
  215. # Not possible for the vascular panel, whose maximum follow-up
  216. # is about 1.6 years. That fact is itself part of the answer.
  217. # ==========================================================
  218. cat("\n=== C. Two-or-more years of follow-up ===\n")
  219. followup_capacity <- map_dfr(primary_markers, function(m) {
  220. d <- long_cc(m) %>% group_by(rid) %>%
  221. summarise(span = max(years_from_baseline) - min(years_from_baseline), .groups = "drop")
  222. tibble(marker = m, n_participants = nrow(d),
  223. n_with_2y_span = sum(d$span >= 2),
  224. pct_with_2y_span = round(100 * mean(d$span >= 2), 1),
  225. max_span = round(max(d$span), 2))
  226. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  227. out$C_followup_capacity <- followup_capacity
  228. sens_2y <- map_dfr(primary_markers, function(m) {
  229. ids <- long_cc(m) %>% group_by(rid) %>%
  230. summarise(span = max(years_from_baseline) - min(years_from_baseline), .groups = "drop") %>%
  231. filter(span >= 2) %>% pull(rid)
  232. d <- long_cc(m) %>% filter(rid %in% ids)
  233. if (n_distinct(d$rid) < 30 || n_distinct(d$baseline_dx) < 2) return(NULL)
  234. extract_long(fit_long(m, d), m, "restricted to 2+ years of follow-up")
  235. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  236. out$C_two_year_followup <- sens_2y
  237. # ==========================================================
  238. # D. MCI CONVERTERS AND TIME-VARYING DIAGNOSIS (Reviewer 2, comment 3)
  239. #
  240. # dx_label is already visit-level, so conversion status and a
  241. # time-varying diagnosis model are both available without new data.
  242. # ==========================================================
  243. cat("\n=== D. Converters ===\n")
  244. conversion <- dat %>%
  245. filter(!is.na(dx_label), !is.na(baseline_dx), !is.na(years_from_baseline)) %>%
  246. arrange(rid, years_from_baseline) %>%
  247. group_by(rid, baseline_dx) %>%
  248. summarise(
  249. n_visits_with_dx = n(),
  250. ever_ad = any(dx_label == "AD"),
  251. ever_mci = any(dx_label == "MCI"),
  252. last_dx = last(dx_label),
  253. time_to_first_ad = { i <- which(dx_label == "AD")
  254. if (length(i)) years_from_baseline[i[1]] else NA_real_ },
  255. followup_span = max(years_from_baseline) - min(years_from_baseline),
  256. .groups = "drop"
  257. ) %>%
  258. mutate(converter = case_when(
  259. baseline_dx == "MCI" & ever_ad ~ "MCI to AD converter",
  260. baseline_dx == "MCI" ~ "stable MCI",
  261. baseline_dx == "CN" & (ever_mci | ever_ad) ~ "CN progressor",
  262. baseline_dx == "CN" ~ "stable CN",
  263. TRUE ~ "AD at baseline"
  264. ))
  265. conversion_summary <- conversion %>%
  266. count(baseline_dx, converter) %>%
  267. group_by(baseline_dx) %>% mutate(percent = round(100 * n / sum(n), 1)) %>% ungroup()
  268. print(as.data.frame(conversion_summary))
  269. out$D1_conversion_summary <- conversion_summary
  270. # Conversion rates within each biomarker analytic sample
  271. out$D2_conversion_by_panel <- map_dfr(primary_markers, function(m) {
  272. ids <- unique(long_cc(m)$rid)
  273. conversion %>% filter(rid %in% ids) %>% count(marker = m, baseline_dx, converter) %>%
  274. group_by(marker, baseline_dx) %>% mutate(percent = round(100 * n / sum(n), 1)) %>% ungroup()
  275. })
  276. # D3. Time-varying diagnosis model
  277. out$D3_time_varying_dx <- map_dfr(primary_markers, function(m) {
  278. d <- long_cc(m) %>% filter(!is.na(dx_label))
  279. if (n_distinct(d$rid) < 30) return(NULL)
  280. fit <- lmer(as.formula(paste0("ln_", m,
  281. " ~ years_from_baseline * dx_label + baseline_age + ptgender + pteducat + apoe4 + (1 | rid)")),
  282. data = d, REML = FALSE)
  283. tidy(fit, effects = "fixed") %>%
  284. filter(grepl("years_from_baseline|dx_label", term)) %>%
  285. mutate(marker = m, analysis = "time-varying diagnosis",
  286. percent_change = (exp(estimate) - 1) * 100,
  287. n_obs = nobs(fit), n_subj = ngrps(fit)[["rid"]])
  288. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  289. # D4. Split the MCI arm into stable and converter
  290. out$D4_mci_split <- map_dfr(primary_markers, function(m) {
  291. d <- long_cc(m) %>%
  292. left_join(conversion %>% select(rid, converter), by = "rid") %>%
  293. mutate(dx_group = factor(case_when(
  294. baseline_dx == "CN" ~ "CN",
  295. converter == "stable MCI" ~ "stable MCI",
  296. converter == "MCI to AD converter" ~ "MCI converter",
  297. baseline_dx == "AD" ~ "AD",
  298. TRUE ~ NA_character_),
  299. levels = c("CN", "stable MCI", "MCI converter", "AD"))) %>%
  300. filter(!is.na(dx_group))
  301. if (n_distinct(d$dx_group) < 3 || n_distinct(d$rid) < 40) return(NULL)
  302. fit <- lmer(as.formula(paste0("ln_", m,
  303. " ~ years_from_baseline * dx_group + baseline_age + ptgender + pteducat + apoe4 + (1 | rid)")),
  304. data = d, REML = FALSE)
  305. tidy(fit, effects = "fixed") %>%
  306. filter(grepl("years_from_baseline|dx_group", term)) %>%
  307. mutate(marker = m, analysis = "MCI split by conversion",
  308. percent_change = (exp(estimate) - 1) * 100)
  309. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  310. # ==========================================================
  311. # E. INFORMATIVE DROPOUT PROBE
  312. #
  313. # Does the baseline biomarker value predict whether a participant
  314. # returns for a follow-up measurement? If it does, dropout is
  315. # informative and the slopes need that caveat.
  316. # ==========================================================
  317. cat("\n=== E. Informative dropout ===\n")
  318. dropout <- map_dfr(primary_markers, function(m) {
  319. ln <- paste0("ln_", m)
  320. d <- long_cc(m) %>% group_by(rid) %>%
  321. mutate(returned = as.integer(n() >= 2)) %>%
  322. filter(years_from_baseline == min(years_from_baseline)) %>%
  323. slice(1) %>% ungroup()
  324. if (n_distinct(d$returned) < 2) return(NULL)
  325. fit <- glm(returned ~ get(ln) + baseline_dx + baseline_age + ptgender + pteducat + apoe4,
  326. data = d, family = binomial)
  327. tidy(fit) %>% filter(grepl("get\\(ln\\)|baseline_dx", term)) %>%
  328. mutate(marker = m, odds_ratio = exp(estimate),
  329. term = dplyr::recode(term, `get(ln)` = "baseline biomarker level (log)"))
  330. }) %>% left_join(marker_info, by = "marker") %>% relocate(label)
  331. out$E_informative_dropout <- dropout
  332. out <- imap(out, function(x, nm) {
  333. if (is.null(x) || (is.data.frame(x) && (nrow(x) == 0 || ncol(x) == 0)))
  334. tibble(note = paste("No rows produced for", nm)) else x
  335. })
  336. # Excel caps sheet names at 31 characters.
  337. names(out) <- substr(make.unique(names(out)), 1, 31)
  338. openxlsx::write.xlsx(out, file.path(results_dir, "sensitivity_analyses.xlsx"),
  339. overwrite = TRUE)
  340. cat("\nDone. Results:", file.path(results_dir, "sensitivity_analyses.xlsx"), "\n")

15_sensitivity_analyses.R at commit 27e05ee, under MIT · at the source

Overview

Authors: Khodakaram Jahanbin1, Alzheimer's Disease Neuroimaging Initiative
  1. Department of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran
Journal: FASEB bioAdvances, volume 8, issue 9, article e70155
Dates: received 14 June 2026; accepted 14 September 2026; published online 19 September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1096/fba.2026-00194 · PMID 42763575 · PMCID PMC13589249 · OpenAlex W7213637425
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: other (modality), human (organism), Alzheimer's / dementia (population), clinical / translational (subfield)
Methods: Connectivity, Statistics
Keywords: Alzheimer's disease, biomarkers, blood–brain barrier, glial fibrillary acidic protein, vascular cell adhesion molecule‐1
Topic: Dementia and Cognitive Impairment Research (Psychiatry and Mental health, Medicine), according to OpenAlex
Funding: National Institutes of Health (U01 AG024904); Department of Defense (W81XWH‐12‐2‐0012)
Citations: not cited yet (Europe PMC); 34 references in the paper

Abstract

Alzheimer's disease (AD) is increasingly recognized as a multicellular disorder involving neurovascular unit dysfunction. Investigating glial and vascular biomarkers together may provide a more integrated view of AD biology. This study characterized baseline distributions, interrelationships, and longitudinal trajectories of plasma glial (GFAP, sTREM2) and vascular/endothelial (VEGF, sICAM‐1, sVCAM‐1) biomarkers across the AD continuum. Using Alzheimer's Disease Neuroimaging Initiative (ADNI) data, this retrospective longitudinal cohort study included a covariate‐complete clinical cohort of 2650 participants classified as cognitively unimpaired (CU), mild cognitive impairment (MCI), or AD dementia. Biomarker‐specific analytic samples were determined by assay availability and complete‐case requirements. Associations were evaluated using covariate‐adjusted linear regression and linear mixed‐effects models with participant random intercepts, adjusted for baseline age, sex, education, and APOE ε4 status. Vascular models were additionally refitted with body mass index, systolic blood pressure, antihypertensive and antidiabetic medication use, smoking history, and estimated glomerular filtration rate. Baseline GFAP showed a robust stepwise elevation from CU to MCI to AD (56.3% higher in AD than CU, q = 1.7 × 10−14; area under the curve 0.82), whereas sTREM2 distributions overlapped across groups. VEGF and sVCAM‐1 were higher in AD than CU (14.1%, q = 0.014; 14.7%, q = 0.002), with areas under the curve of 0.61 and 0.63 and more than 80% distribution overlap. GFAP increased by 4.50% per year in CU participants and sTREM2 by 2.99% per year, with no significant diagnosis‐by‐time interactions for either. Over a 12‐month interval, sICAM‐1 declined in CU participants, and this decline was attenuated in MCI and AD, while sVCAM‐1 increased in CU participants and showed negative diagnosis‐by‐time interactions. The vascular longitudinal findings were unchanged by adjustment for cardiometabolic and renal covariates, by time‐varying diagnosis, and by separating stable MCI from MCI‐to‐AD converters. Correlations among vascular markers were consistent and well estimated, whereas glial‐vascular correlations were based on 64 to 94 overlapping participants and were not significant. Glial and vascular plasma biomarkers did not progress synchronously across the AD continuum. GFAP showed the strongest and most discriminating diagnosis‐associated elevation. Vascular markers showed statistically robust but small group‐level differences with no individual‐level discriminative utility, and their divergent 12‐month trajectories require replication over longer follow‐up before they can be interpreted as stage‐dependent regulation.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above, with 17 matches between paragraphs and lines of code.

Khodakaram/adni-glial-vascular-axis

License: MIT
State: the link answers, verified on 26 September 2026
Evidence: files inventoried
Commit: 27e05ee667a76f7ff19358c4fbb1bca2702607a3, 30 August 2026
Languages: R (15)
Size: 18 files, 15 scripts
Software Heritage: not archived
Found in: the text, “Study Design and Data Source”
Holds: README, license file
Not found: CITATION.cff, environment file, tests, continuous integration, documentation
Tools: tidyverse (15 files), lme4 (6 files), lmerTest (6 files), broom (5 files), car (1 file), pROC (1 file)
Availability: 1 check, the latest on 26 September 2026: the link answers
  • 26 September 2026: the link answers
17 files

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 15 scripts, each with its path and the digest of its content;
  • 17 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data Availability Statement

The data used in this research were obtained from Alzheimer's Disease Neuroimaging Initiative (ADNI) and are available with permission to all researchers.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 2 authors, 5 keywords, 2 funders, 32 references.

Cite

This paper

Jahanbin, K., & Alzheimer's Disease Neuroimaging Initiative. (2026). Glial and Vascular Plasma Biomarkers Across the Alzheimer's Disease Continuum: An ADNI-Based Longitudinal Study. FASEB bioAdvances, 8(9), e70155. https://doi.org/10.1096/fba.2026-00194

BibTeX

@article{jahanbin2026glial,
author = {Jahanbin, Khodakaram and {Alzheimer's Disease Neuroimaging Initiative}},
title = {{Glial and Vascular Plasma Biomarkers Across the Alzheimer's Disease Continuum: An ADNI-Based Longitudinal Study}},
journal = {FASEB bioAdvances},
year = {2026},
month = sep,
volume = {8},
number = {9},
pages = {e70155},
publisher = {Wiley},
issn = {2573-9832},
doi = {10.1096/fba.2026-00194},
url = {https://doi.org/10.1096/fba.2026-00194},
pmid = {42763575},
pmcid = {PMC13589249}
}

RIS

TY - JOUR
AU - Jahanbin, Khodakaram
AU - Alzheimer's Disease Neuroimaging Initiative
TI - Glial and Vascular Plasma Biomarkers Across the Alzheimer's Disease Continuum: An ADNI-Based Longitudinal Study
T2 - FASEB bioAdvances
J2 - FASEB Bioadv
PY - 2026
DA - 2026/09/19
VL - 8
IS - 9
SP - e70155
SN - 2573-9832
PB - Wiley
DO - 10.1096/fba.2026-00194
UR - https://doi.org/10.1096/fba.2026-00194
LA - en
ER -

CSL-JSON

{
"id": "10.1096/fba.2026-00194",
"type": "article-journal",
"title": "Glial and Vascular Plasma Biomarkers Across the Alzheimer's Disease Continuum: An ADNI-Based Longitudinal Study",
"container-title": "FASEB bioAdvances",
"author": [
{
"family": "Jahanbin",
"given": "Khodakaram"
},
{
"literal": "Alzheimer's Disease Neuroimaging Initiative"
}
],
"container-title-short": "FASEB Bioadv",
"volume": "8",
"issue": "9",
"page": "e70155",
"DOI": "10.1096/fba.2026-00194",
"PMID": "42763575",
"PMCID": "PMC13589249",
"ISSN": "2573-9832",
"publisher": "Wiley",
"URL": "https://doi.org/10.1096/fba.2026-00194",
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
19
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s44321-025-00316-1 [code]
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD.
Journal: EMBO molecular medicine
In common: broom, lmerTest, lme4, 1 other tool, Alzheimer's / dementia, 3 references
[2] doi:10.1002/alz.14318 [code]
Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer's disease: A longitudinal study of structural and functional MRI and MRS.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: broom, car, lme4, 1 other tool, other, Alzheimer's / dementia, 2 references
[3] doi:10.1038/s41598-025-17894-2 [code]
Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosis.
Journal: Scientific reports
In common: pROC, broom, car, 3 other tools, clinical / translational
[4] doi:10.1093/braincomms/fcaf493 [code]
Subcortical correlates of developmental language disorder: more than the neostriatum.
Journal: Brain communications
In common: pROC, broom, car, 3 other tools
[5] doi:10.1002/alz.14315 [code]
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: pROC, tidyverse, other, Alzheimer's / dementia, clinical / translational, 3 references
[6] doi:10.1186/s13148-025-02015-7 [code]
Association of blood-based DNA methylation of lncRNAs with Alzheimer's disease diagnosis.
Journal: Clinical epigenetics
In common: pROC, broom, car, 2 other tools, Alzheimer's / dementia, clinical / translational
[7] doi:10.1038/s41467-025-60806-1 [code]
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer's disease.
Journal: Nature communications
In common: broom, lmerTest, lme4, 1 other tool, Alzheimer's / dementia, 2 references
[8] doi:10.1002/ana.27285 [code]
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
Journal: Annals of neurology
In common: lme4, tidyverse, other, Alzheimer's / dementia, clinical / translational, 3 references
[9] doi:10.1038/s41588-026-02722-8 [code]
A multiancestry polygenic risk score for Alzheimer's disease is associated with cognitive decline and neuropathological hallmarks in diverse populations.
Journal: Nature genetics
In common: pROC, lmerTest, lme4, 1 other tool, Alzheimer's / dementia, 1 reference
[10] doi:10.1126/sciadv.aec9291 [code]
Computational mechanisms of perception in autism revealed using games inspired by rodent operant tasks.
Journal: Science advances
In common: pROC, broom, car, 2 other tools

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1096/fba.2026-00194.svg)](https://openscicode.org/badge/doi/10.1096/fba.2026-00194)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1096/fba.2026-00194.svg
   :target: https://openscicode.org/badge/doi/10.1096/fba.2026-00194
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1096/fba.2026-00194"><img src="https://openscicode.org/badge/doi/10.1096/fba.2026-00194.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.